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Abstract
Research applied to the early embryo is required to effectively treat human infertility and to understand the primary mechanisms controlling
development to the blastocyst stage. The present study investigated whether the Na+/K+-ATPase regulates tight junction formation and function
during blastocyst formation. To investigate this hypothesis, three experimental series were conducted. The first experiments defined the optimal
dose and treatment time intervals for ouabain (a potent and specific inhibitor of the Na+/K+-ATPase) treatment. The results demonstrated that
mouse embryos maintained a normal development to the blastocyst stage following a 6-h ouabain treatment. The second experiments investigated
the effects of ouabain treatment on the distribution of ZO-1 and occludin (tight junction associated proteins). Ouabain treatment (up to 6 h) or
culture in K+-free medium (up to 6 h) resulted in the appearance of a discontinuous ZO-1 protein distribution and a loss of occludin
immunofluorescence. The third set of experiments examined the influence of ouabain treatment on tight junction function. Ouabain treatment or
culture in K+-free medium affected tight junction permeability as indicated by an increase in the proportion of treated embryos accumulating both
4 kDa and 40 kDa fluorescein isothiocyanate (FITC)-dextran into their blastocyst cavities. The results indicate that the Na+/K+-ATPase is a potent
regulator of tight junction formation and function during mouse preimplantation development.
D 2005 Elsevier Inc. All rights reserved.
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Introduction
Unraveling the mechanisms that direct how embryonic cells
segregate and differentiate is central to understanding normal
tissue development, disease states and to providing insight into
the mechanisms that govern early development (Rajasekaran
et al., 2003a; Johnson and McConnell, 2004). The preimplan-
tation mouse embryo is an elegant system to investigate the
regulation of epithelial cell differentiation (Wiley, 1988; Wiley
et al., 1990; Fleming et al., 2001; Watson and Barcroft, 2001;
Johnson and McConnell, 2004). This process is of fundamental
importance in biology and medicine, since epithelia are the
most common cell type and alterations in their differentiative
pathways occur in many disease states, including carcinomas
(Contreras et al., 1995a). The present study was conducted to
examine the role of Na+/K+-ATPase in regulating tight junction
(TJ) formation and function in the mouse blastocyst.
The blastocyst is composed of the first differentiated cell
type of mammalian development, the outer epithelial trophec-
toderm (TE), surrounding a large fluid-filled cavity and a small
group of cells, called the inner cell mass (ICM), that are the
progenitors of all embryonic cell lineages (Watson and
Barcroft, 2001; Johnson and McConnell, 2004). Following
blastocyst formation the embryo frees itself from its surround-
ing zona pellucida and initiates contact between the TE and the
endometrium to mediate attachment and implantation into the
uterus. Blastocyst formation is essential for implantation,
establishment of pregnancy and is a principal determinant of
embryo quality prior to embryo transfer (Watson and Barcroft,
2001).
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During compaction (which precedes blastocyst formation)
the outside cells of the 8-cell mouse embryo begin to flatten
against one another and eventually become attached by tight
junctions (TJ), adherens junctions (AJ), desmosomes, and gap
junctions (GJ) (Watson et al., 1990a,b; Kidder, 1992; Fleming
et al., 2000a,b). The close cell-to-cell contacts that develop are
due to the presence of the Ca2+-mediated cell adhesion
molecule E-cadherin, which progressively becomes distributed
to areas of cell–cell contact and becomes absent from the free
apical areas of the outer cells (Johnson and Ziomek, 1981;
Johnson et al., 1986; Ohsugi et al., 1997; Torres et al., 1997).
At the same time focal TJ appear which eventually divide the
plasma membrane of the outer blastomeres into separate apical
and basolateral membrane domains (Fleming et al., 2000a,b).
The acquisition of cell polarity is accompanied by a reduction
in cell totipotency as the outer polar cells of the embryo
become committed to the TE cell lineage (Fleming et al.,
2000a; Johnson and McConnell, 2004).
As TE cells differentiate Na+/K+-ATPase becomes confined
to the basolateral membrane domain of the differentiating outer
cells establishing trans-epithelial ion transport (Benos et al.,
1985; Watson and Kidder, 1988; Biggers et al., 1988; MacPhee
et al., 1994; Baltz et al., 1997; MacPhee et al., 2000; Houghton
et al., 2003; Barcroft et al., 2004). This is accompanied by the
formation of a TJ permeability seal that regulates paracellular
transport and maintains the polarized Na+/K+-ATPase distribu-
tion (Watson et al., 1990a; Fleming et al., 2000a, 2001). The
fluid movement across the TE is thought to flow down the Na+
gradient (Benos et al., 1985; Watson and Barcroft, 2001).
Although fluid accumulation during cavitation has been
attributed to simple diffusion, blastocyst formation may occur
in the absence of a steep osmotic gradient across the TE
(Borland et al., 1977; Biggers et al., 1988; Baltz et al., 1997).
Therefore, water movement across the TE could represent near
iso-osmotic water transport, facilitated by water channels or
aquaporins located in TE cell membranes (Offenberg et al.,
2000; Barcroft et al., 2003).
Na+/K+-ATPase is specifically inhibited by the cardiac
glycoside, ouabain (Schoner, 2002; Schneeberger and Lynch,
2004). Apart from the subtle differences in reactivity toward
Na+, K+ and ATP, the most significant differences in Na+/K+-
ATPase isozymes correspond to reactivity towards ouabain
(Jewell and Lingrel, 1991; Mobasheri et al., 2000). The sheep
and human enzymes are a thousand times more sensitive than
the corresponding ones from rat and mouse (Price and Lingrel,
1988; Price et al., 1990; Contreras et al., 1995b). In addition
results from gene targeting experiments have demonstrated that
Na+/K+-ATPase a1-subunit null mutants are never born and
suffer a developmental lethality, while Na+/K+-ATPase a2-
subunit null mutants are born but do not survive the first day
post partum (Lingrel et al., 2003). We have reported that mouse
embryos homozygous for a null mutation in the Na+/K+-
ATPase a1-subunit gene undergo compaction and cavitation
but subsequently fail during the peri-implantation phase of
development (Barcroft et al., 2004).
As we learn more about the ways in which epithelial
cells regulate their paracellular permeability, questions arise
as to the manner in which the preimplantation embryo
maintains the fluid that accumulates within the blastocoel
cavity and the regulation of TJ seals to maintain the
basolateral location of Na+/K+-ATPase required for blasto-
cyst development. Recent studies applied to MDCK cell
cultures have demonstrated that assembly and maintenance
of the TJ in epithelia is dependent on the phosphorylated
state of the cadherin/catenin complex and also on Na+/K+-
ATPase activity (Rajasekaran and Rajasekaran, 2003; Raja-
sekaran et al., 1996, 2001a,b, 2003a,b). Inhibition of the
Na+/K+-ATPase in cell cultures by either ouabain treatment
or culture in K+ depleted medium prevents the formation of
TJ, detaches cells from each other and from their substrate
and inhibits the acquisition of cell polarity (Contreras et al.,
1999; Rajasekaran et al., 2003a,b). A relationship between
Na+-pump and TJ formation within the blastocyst would
reveal an enhanced role for the increased Na+/K+-ATPase
expression and activity observed during the morula–blasto-
cyst transition (Betts et al., 1997). For these reasons the
current study was conducted to investigate whether the Na+/
K+-ATPase is involved in the regulation of TJ formation and
function during TE differentiation. The primary hypothesis
of this study is that Na+/K+-ATPase mediates TE TJ
formation and function during blastocyst development. Our
results indicate that mouse embryos recover and develop
normally to the blastocyst stage following ouabain treatment
(up to 6 h). More importantly ouabain treatment or culture
in K+-free medium affects the distribution of TJ marker
proteins (ZO-1 and occludin) and TJ permeability in mouse
blastocysts indicating that Na+/K+-ATPase plays a role in the
regulation of TJ formation and function during preimplan-
tation development.
Materials and methods
Mouse embryo collection and culture
For collection of mouse preimplantation embryos CD1 females (4–6 weeks
of age; Charles River Canada Ltd., St. Constant, QC) were superovulated by
intraperitoneal injection of 5 i.u. pregnant mares serum gonadotropin (PMSG;
Invitrogen Canada Inc. Burlington, ON) followed 46 h later by 5 i.u. human
chorionic gonadotropin (hCG; Invitrogen Canada Inc. Burlington, ON).
Following the hCG injection females were placed with CB6F1/J males (The
Jackson Laboratory, Bar Harbor, ME). Successful mating was determined the
following morning (day 1) by detection of a vaginal plug. Embryos were
flushed from dissected oviducts and uteri using flushing medium-I (Spindle,
1980; 70–72 h post-hCG for 8-cell stage embryos; 82 h post-hCG for morula;
96 h post-hCG for blastocysts) and cultured in potassium simplex optimized
medium with amino acids (KSOMaa) (Summers et al., 1995) under a 5% CO2
in air atmosphere at 37-C until transferred into experimental treatment groups
as defined below. All medium components were purchased from Sigma (St.
Louis, MO) unless stated otherwise. KSOMaa medium was made fresh before
each collection and was sterile filtered. The osmolarity of the medium was
tested each time it was prepared and ranged between 288 and 298 mOsm. All
experiments described in this study, maintained a treatment drop volume to
embryo ratio of one embryo per Al of KSOMaa culture medium.
Optimization of ouabain dose and treatment time on development
Embryo development following long-term ouabain treatment
To assess the effects of ouabain treatment on development 8-cell stage
embryos were placed into treatment groups consisting of a control group,
KSOMaa alone (Summers et al., 1995), and treatment groups in KSOMaa
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including 107 M, 105 M, and 103 M ouabain (103 M concentration known
to block mouse blastocyst re-expansion following cytochalasin D induced
collapse; DiZio and Tasca, 1977; Wiley, 1984; Betts et al., 1997). Each
treatment group consisted of 25 8-cell stage embryos in 25 Al culture drops
under mineral oil and incubated at 37-C, under a 5% CO2 in air
atmosphere for 48 h. For each experimental replicate, development was
assessed at 24-h intervals. Blastocoel diameter was measured with an ocular
micrometer at the end of the experimental period. Eight experimental
replicates were conducted, and in total 800 mouse embryos were treated,
measured, and scored for development.
Determination of cell number
To count blastocyst nuclei embryos from each treatment group were treated
at the conclusion of each experiment with DAPI (4V,6-diamidino-2-phenylin-
dole; 1 Ag/Al in PBS) for 20 min at 38-C in a humidified chamber. Following
DAPI treatment embryos were washed 2 in fresh PBS without DAPI for 20
min before being mounted onto glass slides, and examined with a Zeiss LSM
410 Confocal Laser Scanning Microscope. Embryos were scanned through
10 Am Z-plane sections.
Embryo development following short-term ouabain treatment
To determine embryo development following short-term ouabain treatment,
morula (82 h post-hCG) stage mouse embryos were collected and divided into
four treatment groups and cultured in KSOMaa, (15–20 morulae in 15–20
Al drops under oil at 37-C, under a 5% CO2 in air atmosphere per replicate) as
follows: (1) morulae cultured in KSOMaa for 3 h and 6 h, followed by 24 h of
fresh KSOMaa medium (control); (2) morulae cultured for 3 h and 6 h in
KSOMaa plus 105 M ouabain, followed by 24 h in ouabain-free KSOMaa; (3)
morulae cultured for 3 h and 6 h in KSOMaa media plus 104 M ouabain,
followed by 24 h in ouabain-free KSOMaa; (4) morulae cultured for 3 h and 6 h
in KSOMaa plus 103 M ouabain, followed by 24 h in ouabain-free KSOMaa.
Embryo development was assessed at 12 h, and 24 h following treatment. Five
replicates were conducted, and in total 600 mouse morulae were treated and
evaluated for blastocyst development. Sub-sets of treated embryos were fixed
in 2% paraformaldehyde (PFA) in phosphate-buffered saline (PBS) (GIBCO\
BRL Invitrogen Canada Inc. Burlington, ON) for 30 min and processed to
assess the localization of the TJ protein, ZO-1, by immunofluorescence
methods (see below).
Influence of ouabain treatment on the distribution of TJ associated
ZO-1 protein
Recovery from cytochalasin D induced blastocyst formation is an
established method for assessing TJ re-assembly and blastocyst formation
(DiZio and Tasca, 1977; Betts et al., 1998). Embryos were collected at the
compacting 8-cell (72 h post-hCG) and morula stages (82 h post-hCG) and
allowed to progress to the blastocyst stage in KSOMaa (30 Al drops under oil at
37-C, 5% CO2 in air atmosphere). Blastocysts were treated with 20 Ag/ml
cytochalasin D for 2 h disrupting the actin filamentous cytoskeleton and
collapsing the blastocoel cavity (Cooper, 1987). A subset of blastocysts were
left out of the cytochalasin treatment as untreated controls and were cultured in
KSOMaa for the entire experimental interval. The cytochalasin D treated
embryos were split into two treatment groups: (1) cytochalasin D treatment for
2 h followed by 3 h or 6 h in drug-free KSOMaa (control); (2) cytochalasin D
treatment for 2 h followed by 3 h or 6 h in KSOMaa plus 103 M ouabain. At
each time interval (3 h or 6 h), embryos were removed from treatment and fixed
in 2% PFA in PBS and stored at 4-C in PBS until required. Three experimental
replicates were conducted, and in total 360 mouse blastocysts were treated and
evaluated for effects on the distribution of TJ ZO-1 by immunofluorescence.
Influence of Short term Na/K-ATPase blockade on the distribution of
TJ associated proteins ZO-1 and occludin
To define the consequences of short-term Na/K-ATPase blockade on the
distribution of TJ associated proteins blastocysts were collected and divided
into four treatment groups (15–20 blastocysts in 15–20 Al drops under oil at
37-C, under a 5% CO2 in air atmosphere per replicate) as follows: (1)
blastocysts cultured in KSOMaa for 3 h and 6 h (control); (2) blastocysts
cultured for 3 h and 6 h in KSOMaa plus 103 M ouabain; (3) blastocysts
cultured for 3 h and 6 h in K+-free KSOMaa media (K+-free KSOMaa; KCl and
KH2PO4 in KSOMaa were substituted with NaCl and NaH2PO4 of equal
molarity; the osmolarity of the medium was tested each time it was prepared
and ranged between 288 and 298 mOsm); and (4) blastocysts cultured for 3
h and 6 h in KSOMaa plus 2 mM EGTA (a positive control that disrupts tight
junctions). In total, 160 murine blastocysts were fixed in 2% PFA in PBS
immediately after treatment and stored at 4-C in PBS until required for analysis
of TJ protein ZO-1 and occludin distribution by immunofluorescence methods
(see below). To count blastocyst nuclei embryos from each treatment group
were treated with DAPI (as above).
Antisera
The primary antisera used included a rat monoclonal IgG raised against the
TJ protein ZO-1 from mouse liver (Chemicon International; Temecula, CA) and
a mouse monoclonal IgG raised against human occludin (Zymed Laboratories,
Inc., San Francisco, CA). These antisera have been extensively characterized by
Western blot analysis (Stevenson et al., 1986) and immunofluorescence studies
(Stevenson et al., 1986; Fleming et al., 1989) of mammalian tissues, cultured
cells and mouse preimplantation embryos. Embryos were incubated with a 1:50
dilution of either ZO-1 or occludin antisera in Wash Buffer [PBS + 0.005%
Triton X + 0.05% NDS]. A fluorescein isothiocyanate (FITC)-conjugated goat
anti-rat (GARF) IgG was used as a secondary antibody for ZO-1 1:100 dilution
(Sigma, St. Louis, MO). A FITC-conjugated donkey anti-mouse (DAMF) IgG
was used as a secondary antibody for occludin 1:200 dilution (Jackson Labs,
West Grove, PA).
Immunofluorescence methods and confocal microscopy
Following each experiment embryos from each treatment were washed in
PBS and fixed in 2% PFA in PBS at room temperature for 30 min for
application of immunofluorescence methods. Fixed embryos were washed once
in PBS and either used immediately or stored at 4-C in Embryo Storage Buffer
[PBS + 0.9% sodium azide] for up to 1 week before processing for whole-
mount immunofluorescence. Fixed embryos were permeabilized and blocked
for 30 min in Immuno-Block [PBS + 0.01% Triton X + 5% NDS] and then
washed in Antibody Dilution Buffer [PBS + 0.005% Triton X + 0.05% NDS].
Embryos were incubated with primary antiserum prepared in and subsequently
washed in Antibody Dilution Buffer overnight at 4-C in a humidified chamber.
Excess primary antibody was removed by washing embryos 3, the first 2
washes 20 min, and the third wash 30 min at 37-C in a 9-well Pyrex plate
placed in a humidified box. Embryos were then incubated with FITC-
conjugated secondary antiserum. Excess secondary antibody was removed by
washing embryos 3, the first wash containing DAPI (1 Ag/Al) for nuclear
staining for 20 min at 38-C; the final 2 washes were 20 min in Antibody
Dilution Buffer. Non-specific fluorescence staining contributed by the
secondary antiserum was determined by treating a small pool of embryos with
only the FITC-conjugated secondary IgG. These embryos were subjected to the
same incubation and wash protocol as described. Embryos were mounted in 20
Al Fluoro-Guard [to prevent photobleaching] (Bio-Rad Laboratories (Canada)
Ltd.; Mississauga, ON) on glass slides under glass cover slips with vaseline on
each corner of the coverslip (to prevent crushing embryos), and sealed with nail
polish. The distribution of ZO-1 or occludin protein within the embryos was
visualized using a Zeiss LSM 410 Confocal Laser Scanning Microscope. The
ZO-1 and occludin fluorescence distribution was judged as negative if no
fluorescence was detected within cell margin regions, discontinuous if marginal
areas displayed a disrupted linear fluorescence pattern, or continuous if all
marginal areas displayed a linear Fbelt-like_ fluorescence (Eckert et al., 2004).
Influence of ouabain treatment on TJ permeability in mouse
blastocysts
To investigate the effects of ouabain treatment on TJ permeability a series
of experiments were conducted to examine effects of treatment on accumula-
tion of FITC-dextran (4 kDa, 40 kDa and 70 kDa) into the blastocyst cavity of
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treated embryos. For each experiment treatment groups included: (1) KSOMaa
medium (control); (2) KSOMaa medium plus 2 mM EGTA; (3) KSOMaa
medium plus 103 M ouabain; and (4) K+-free KSOMaa medium. Blastocysts
were placed into each treatment group for 3 h and 6 h and were cultured in 10–
15 Al drops under standard conditions as described. Following treatment
blastocysts were incubated in KSOMaa containing 1 mg/ml fluorescein
isothiocyanate (FITC)-dextran of size 4 kDa (Sigma, St. Louis, MO) for 30
min, washed 3 in dextran-free KSOMaa and viewed immediately by
fluorescence microscopy. Each embryo was scored for the presence or absence
of FITC-dextran within the blastocoel cavity. Four replicates were conducted,
and in total 321 blastocysts were assessed for 4 kDa FITC-dextran permeability.
Sixteen additional replicates of this experimental design were conducted to
investigate TJ permeability to 40 kDa and 70 kDa FITC-dextran. Each
experimental replicate in these series included an additional 103 M ouabain
treatment group (positive control incubated in 4 kDa FITC-dextran) to ensure
consistency of outcomes between experiments. In total, 821 blastocysts were
assessed for 40 kDa and 70 kDa FITC-dextran TJ permeability after ouabain
treatment or exposure to K+-free medium. In a final experiment, eight
experimental replicates (639 blastocysts) were conducted to investigate whether
ouabain treatment with 105 M and 104 M ouabain for 6 h also affected TJ
permeability to 4 kDa FITC-dextran.
Statistical analysis
Results are presented as an average mean T SEM for the number of
embryos indicated. Statistical analysis was performed using one-way ANOVA
and Dunn’s multiple comparison test or two-way ANOVA followed by Tukey’s
post hoc test where appropriate. The non-parametrical equivalent test
(Kruskal–Wallis) was used when samples did not meet the assumption of
normal distribution or homogeneity of variance. Data calculations were
preformed using SigmaStati software (Jandel Scientific, San Rafael, CA,
USA) and means were considered statistically significant when P < 0.05.
Results
Embryo development and cell number following long-term
ouabain treatment
To define the optimal levels for ouabain treatment, dose
response experiments were conducted by collecting 8-cell stage
embryos and monitoring effects to development for up to 48 h.
In the first experiment the concentrations of ouabain employed
were 107 M, 105 M, and 103 M. Ouabain concentration had
a significant influence on both development to the blastocyst
stage and blastocoel diameter (Figs. 1A and B). Embryos
treated with 103 M ouabain did not progress beyond the 8-cell
stage (Figs. 1A and B). In contrast, embryos treated with 107
M and 105 M ouabain or drug-free KSOMaa all displayed a
normal development to the blastocyst stage (Figs. 1A and B).
Embryo cell number decreased as concentrations of ouabain
increased (Fig. 1C). There was a significant difference in cell
number between the 103 M ouabain treatment group and the
other 3 treatment groups as well as between the 105 M
ouabain treatment group and control group (P  0.05). No
significant difference in cell number was detected between the
control and 107 M ouabain treatment group or between the
107 M and 105 M ouabain treatment groups (Fig. 1C). The
results demonstrated that 8-cell mouse embryos subjected to a
long-term treatment (>24 h) with 107 M or 105 M ouabain
survive and progress to the blastocyst stage. Eight-cell embryos
treated long term with 103 M ouabain are unable to progress
beyond the 8-cell stage of development.
Embryo development following short-term ouabain treatment
Since the long-term treatment experiment determined that
treatment with 103 M ouabain blocked embryo development
we next characterized the outcomes from shorter term ouabain
treatments. For this experiment, ouabain concentrations of
105 M, 104 M, and 103 M and treatment times of 3 h and 6
h applied to mouse morulae were investigated. The results
demonstrated that there were no significant differences in
blastocyst development in any of these ouabain concentration
or treatment time groups (Fig. 1D). Therefore, treatment of
mouse morulae for up to 6 h with 103 M ouabain does not
impair development to the blastocyst stage.
Influence of ouabain treatment on the distribution of TJ
associated ZO-1 protein
Our first experiments also included an examination of ZO-1
distribution following long-term culture in the presence of
ouabain. Long-term culture in the presence of 107 M or 105
M ouabain did not affect ZO-1 distribution (data not shown).
Since the short-term experiments defined a treatment interval
(up to 6 h) and ouabain concentration (103 M) where embryo
viability was not affected subsequent experiments employed
this short time course (3 and 6 h) followed by 24 h culture in
drug-free KSOMaa to analyze effects to TJ formation, re-
assembly and distribution of TJ-associated proteins, ZO-1 and
occludin. Experiments examined the influence of ouabain
treatment on ZO-1 distribution following TJ formation and also
TJ re-assembly following cytochalasin-d induced blastocyst
collapse. ZO-1 normally displays a fluorescence pattern that is
confined to the apico-lateral margins between cells of the outer
TE layer (Fleming et al., 1989). ZO-1 fluorescence forms an
uninterrupted belt at the perimeter of each cell corresponding to
the region where mature TJs form (Fleming et al., 1989). Our
results confirmed these findings as the ZO-1 distribution in
embryos cultured in KSOMaa (control) medium appeared as a
continuous linear Fbelt-like_ fluorescence encircling the apico-
lateral periphery of each TE cell (Fig. 2ACon; and BCon).
Embryos treated with 105 M and 104 M ouabain for
3 h and 6 h displayed an identical ZO-1 fluorescence pattern
as controls (Fig. 2A 105 and 104 and 2B 105 and 104). In
contrast, all embryos (>50 embryos per group) treated with
103 M ouabain for 3 h (A 103 M) and 6 h (B 103 M)
followed by 24 h in drug-free medium displayed a ZO-1
fluorescence pattern that transitioned from continuous to
discontinuous by the 6 h treatment time. Following 6 h of
treatment there was an obvious decline in the intensity of Z0-1
immunofluorescence (B 103 M).
Influence of ouabain treatment and culture in K +-free
KSOMaa on the distribution of ZO-1 and Occludin
To establish the effects of Na/K-ATPase blockade on
blastocyst TJ, we next contrasted the effects of both ouabain
treatment and culture in K+-free KSOMaa medium on the
distribution of ZO-1 and also occludin, a core TJ protein. The
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ZO-1 distribution in all embryos cultured in KSOMaa medium
once again appeared as a continuous linear Fbelt-like_
fluorescence encircling the apico-lateral periphery of each
TE cell (Fig. 3B KSOM). Occludin fluorescence mimicked the
ZO-1 pattern in all KSOM control blastocysts (Fig. 3A
KSOM). In contrast to these results but consistent with earlier
experiments all blastocysts cultured in the presence of 103 M
ouabain displayed a discontinuous fluorescence pattern for
ZO-1 (Fig. 3B ouabain). Occludin fluorescence was reduced
to minimal levels in all embryos in the 103 M ouabain
treatment group (Fig. 3A ouabain). All blastocysts cultured in
K+-free KSOMaa medium displayed identical discontinuous
Fig. 1. Development of Mouse Embryos Following Ouabain treatment. (A) Influence of ouabain treatment at the 8 cell stage on blastocoel diameter. Embryos were
placed into control medium (KSOMaa), or KSOMaa plus ouabain at 107 M, 105 M or 103 M. Embryos cultured in 107 M ouabain displayed a significant (P 
0.05) increase in blastocoel diameter compared to embryos cultured in KSOMaa medium alone or KSOMaa plus 103 M ouabain. Embryos cultured in 103 M
ouabain from the 8-cell stage remained at the 8-cell stage. (B) Morphology of embryos cultured from the 8-cell stage in KSOMaa or KSOMaa medium with 107 M,
105 M and 103 M ouabain. Scale bar = 100 Am. (C) Effects of long-term ouabain treatment on blastocyst cell number. Embryos cultured in 103 M ouabain
displayed a significant (P  0.05) decrease in cell number compared to those cultured in KSOMaa, or 107 M and 105 M ouabain. Embryos cultured in 105 M
ouabain displayed a significant (P  0.05) decrease in cell number compared to those cultured in drug-free KSOMaa. (D) Influence of short-term ouabain treatment.
Embryos at the morulae stage were treated for 3 h (3 h) or 6 h (6 h) in KSOMaa, or KSOMaa plus 105 M, 104 M or 103 M ouabain. Blastocyst development or
cell number (data not shown) did not vary significantly (P  0.05) among any of the treatment groups for either a 3 or 6 h treatment interval.
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ZO-1 and occludin fluorescence patterns to that observed for
blastocysts cultured in medium with 10 M ouabain (Fig. 3A
K+-free KSOMaa and 3B K+-free KSOMaa). Blastocysts
cultured in medium with 2 mM EGTA displayed normal ZO-1
and occludin fluorescence patterns (Fig. 3A EGTA and 3B
EGTA). No difference in blastocyst cell number was observed
in any of these treatment groups following the 6 h treatment
interval indicating that a short term treatment with 103 M
ouabain did not affect overall blastocyst cell number (data not
shown).
Influence of ouabain treatment on the re-distribution of ZO-1
following TJ disruption
Now that it was apparent that ouabain treatment, for as short
an interval as 6 h affected the distribution of TJ associated
Fig. 2. Effects of 3 h and 6 h Ouabain Treatment on ZO-1 Distribution. Control blastocysts displayed a continuous linear Fbelt-like_ ZO-1 fluorescence pattern
confined to the apical surface of the developing TE (A Control, B Control).Embryos treated with 105 M and 104 M ouabain for 3 h (A 105 M and A 104 M) and
6 h (B 105 M and B 104 M) displayed an identical ZO-1 fluorescence pattern as untreated controls. In contrast, embryos treated with 103 M ouabain for 3 h
(A 103 M) and 6 h (B 103 M) displayed a ZO-1 fluorescence pattern that transitioned from continuous to discontinuous by the 6 h treatment time. No fluorescence
was observed in embryos treated with secondary antibody alone (A 103 M inset; and B 103 M inset). All images are 1 Am thick confocal laser scanning
projections. Scale bars = 25 Am.
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proteins, we next investigated whether ouabain treatment could
also affect TJ ZO-1 distribution during junctional re-assembly
following cytochalasin-d induced blastocyst collapse. Follow-
ing 2 h of cytochalasin-d treatment, ZO-1 fluorescence was
primarily cytoplasmic and discontinuous running along the
outer margins of each blastomere in all embryos (Figs. 4D and
G). In control untreated blastocysts, ZO-1 displayed the
expected continuous belt-like fluorescence pattern along the
cell margins of each TE cell (Figs. 4A, B and C). At 3
h following cytochalasin-d treatment, embryos placed into
drug-free KSOMaa medium still displayed a discontinuous
linear ZO-1 fluorescence pattern (Fig. 4E). These embryos
often revealed the re-appearance of fluid-filled cavities (not
shown). By 6 h in drug-free KSOMaa medium a continuous
belt-like ZO-1 fluorescence pattern was restored and all of
these embryos displayed the appearance of a fluid-filled cavity
Fig. 3. Effects of Ouabain Treatment on ZO-1 and Occludin Distribution. Control blastocysts displayed a continuous ZO-1 and occludin fluorescence pattern
confined to the apical surface of developing TE (A, Control; B, Control). Blastocysts cultured in medium plus 2 mM EGTA displayed identical ZO-1 and occludin
fluorescence patterns to that observed in controls (A, EGTA and B, EGTA). In contrast the ZO-1 fluorescence pattern transitioned to become discontinuous for
blastocysts cultured in the presence of 103 M ouabain for 6 h (B, ouabain) and also for blastocysts cultured in K+-free KSOMaa for 6 h (B, K+-free KSOMaa). In
addition to becoming discontinuous, the occludin fluorescence pattern was also markedly reduced for blastocysts cultured in 103 M ouabain (A, ouabain) and K+-
free KSOMaa for 6 h (B, K+-free KSOMaa). All images are 1 Am thick confocal laser scanning projections. Scale bars = 25 Am.
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(Fig. 4F). In contrast, re-expansion of mouse blastocysts was
completely blocked in all embryos (>50 embryos) placed into
the ouabain treatment group following cytochalasin D treat-
ment (Figs. 4G–I). The ouabain treated embryos displayed a
discontinuous ZO-1 fluorescence pattern in both 3 h and
6 h treatment time points (Figs. 4H and I). Therefore
treatment with 103 M ouabain prevented recovery from
cyctochalasin-D collapse and more importantly was associated
with the retention of a discontinuous ZO-1 distribution.
Influence of ouabain treatment on TJ permeability in mouse
blastocysts
The results to this point indicated that early mouse embryos
can survive a 6 h treatment with 103 M ouabain and this
treatment or culture in K+-free KSOMaa medium are associ-
ated with an abnormal ZO-1 and occludin protein distribution.
The final experimental series investigated whether Na/K-
ATPase blockade by either ouabain treatment or culture in
Fig. 4. Effects of Ouabain Inhibition on TJ Re-assembly. Blastocysts were treated in cytochalasin D for 2 h (D and G). Control embryos not exposed to cytochalasin
D displayed the expected ‘‘continuous’’ belt-like ZO-1 fluorescence pattern along the TE cell margins at all time points (0 h A; 3 h B; 6 h C). At 3 h following
cytochalasin D treatment embryos placed into drug-free KSOMaa still displayed a discontinuous linear ZO-1 fluorescence pattern (E). However, a continuous belt-
like ZO-1 fluorescence pattern was established by 6 h in drug-free KSOMaa (F). The ouabain treated embryos maintained a discontinuous ZO-1 fluorescence
patterns at all time points (3 h, H; 6 h, I). No fluorescence was observed in embryos treated with secondary antibody alone (J). All images are 1 Am thick confocal
laser scanning projections. Scale bars = 25 Am.
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K+-free KSOMaa medium affected TJ function as assessed by
examining FITC-dextran accumulation in treated blastocysts.
We first examined effects to 4 kDa FITC dextran
accumulation. Table 1 shows that following 3 h, all three
treatment groups, KSOM plus 103 M ouabain, KSOMaa plus
EGTA, and K+-free KSOMaa medium displayed a significant
increase over untreated controls in the number of embryos that
accumulated 4 kDa FITC-dextran into their blastocyst cavities
(P < 0.05). Table 2 demonstrates that by 6 h of treatment, the
proportion of embryos that displayed 4 kDa FITC-dextran
fluorescence in their blastocyst cavities had increased in each
group but was still significantly greater in the three treatment
groups over that observed for untreated controls.
The next experimental series examined the effects of
treatment on accumulation of 40 kDa and 70 kDa FITC-
dextran. Tables 1 and 2 show that for accumulation of 40 kDa
FITC-dextran all three treatment groups (103 M ouabain, K+-
free group and EGTA group) displayed a significant difference
(P < 0.05) over untreated controls in the proportion of embryos
that displayed FITC-dextran in their blastocyst cavities.
Representative images of FITC-dextran fluorescence within
the blastocoel of treated embryos at 3 h (Figs. 5A–D) and 6
h (Figs. 5 E–H) are displayed in Fig. 5. However, in contrast to
these, results Tables 1 and 2 reveal that accumulation of 70 kDa
FITC-dextran was only significantly greater in the EGTA
treated control group for both 3 h and 6 h treatments. Thus
ouabain treatment or culture in K+-free KSOMaa medium had
no effect on accumulation of 70 kDa FITC-dextran.
The final experiment investigated whether treatment with
lower ouabain concentrations would also affect FITC dextran
accumulation. Table 3 indicates that treatment with 105 M and
104 M ouabain for 6 h had no significant influence on
accumulation of 4 kDa FITC-dextran. In contrast, Table 3
shows that the EGTA, 103 M ouabain and K+-free treatment
groups displayed a significant increase in the proportion of
embryos accumulating 4 kDa FITC-dextran into their blasto-
cyst cavities (P < 0.05).
Discussion
In this study we have demonstrated that treatment of mouse
embryos with a potent Na+/K+-ATPase inhibitor or culture in
K+-free KSOMaa medium affects the maintenance of TJ
structure and function during preimplantation development.
We have demonstrated that mouse embryos can be treated with
ouabain at concentrations as high as 103 M for up to 6 h
without apparent detriment as indicated by their continued
development to the blastocyst stage and their maintenance of a
normal cell number. Of even greater significance, the results
indicate that ouabain treatment or culture in K+-free KSOMaa
medium both result in an increase in TE TJ permeability to 4
kDa and 40 kDa FITC-dextran. This increased TJ permeability
was accompanied by a re-arrangement of the distribution of
ZO-1 and occludin, both important TJ associated proteins.
Collectively the results suggest that Na+/K+-ATPase is a potent
regulator of TE tight junction function during murine
preimplantation development.
Blastocyst formation is dependent upon the expression of
several gene products including Na+/K+-ATPase, E-cadherin,
and TJ components (Fleming et al., 1989; Ohsugi et al., 1997;
Fleming et al., 2000a,b; Barcroft et al., 2004). This morpho-
genetic event is initiated during compaction as stable E-
Table 1
FITC-dextran permeability in embryos treated with ouabain for 3 h
3 h Treatment time
FITC-dextran size 4 kDa 40 kDa 70 kDa
No. of embryos
examined
No. of permeable
embryos
No. of embryos
examined
No. of permeable
embryos
No. of embryos
examined
No. of permeable
embryos
Treatment group
KSOMaa 42 6 (14.2%) 49 5 (10.2%) 40 1 (2.5%)
103 M Ouabain 43 20 (46.5%)* 58 18 (31.0%)* 39 2 (5.1%)
K+-free 40 17 (42.5%)* 50 22 (44.0%)* 39 1 (2.5%)
EGTA 39 23 (58.9%)* 53 26 (49.0%)* 38 13 (34.2%)*
* Significantly different from control by Dunn’s Test P < 0.05.
Table 2
FITC-dextran permeability in embryos treated with ouabain for 6 h
6 h Treatment time
FITC-dextran size 4 kDa 40 kDa 70 kDa
No. of embryos
examined
No. of permeable
embryos
No. of embryos
examined
No. of permeable
embryos
No. of embryos
examined
No. of permeable
embryos
Treatment group
KSOMaa 39 6 (15.3%) 58 5 (8.6%) 45 3 (6.6%)
103 M Ouabain 40 21 (52.5%)* 63 17 (26.9%)* 48 6 (12.5%)
K+-free 39 20 (51.2%)* 79 25 (31.6%)* 48 5 (10.4%)
EGTA 39 29 (74.3%)* 63 35 (55.5%)* 51 14 (27.4%)*
* Significantly different from control by Dunn’s Test P < 0.05.
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cadherin/catenin cell-to-cell AJs form as a prelude to focal TJ
formation (Fleming et al., 2000a,b). TE differentiation pro-
ceeds as TJs mature and assist in the establishment of distinct
apical and basolateral cell membrane domains. By the late
morula stage, the a1 subunit of the Na+/K+-ATPase is up-
regulated and this occurs in combination with the polarized
localization of Na+/K+-ATPase to the basolateral domains of
the outer TE, at the onset of fluid accumulation (Watson and
Kidder, 1988; Watson et al., 1990b; Betts et al., 1998). It is
hypothesized that the formation of the blastocyst cavity is
facilitated by a trans-trophectodermal ion gradient established
by a polarized distribution of Na+/K+-ATPase, which facilitates
the movement of water into the extracellular space to form the
fluid-filled cavity of the blastocyst (Benos et al., 1985; Biggers
et al., 1988; Watson and Barcroft, 2001; Barcroft et al., 2004).
However, blastocyst expansion only occurs after the TJ
permeability seal fully forms to restrict the leakage of fluid
via paracellular routes, ensuring the expansion of the cavity as
fluid accumulates (McLaren and Smith, 1977; Sheth et al.,
2000a).
Several studies have implicated Na+/K+ATPase activity and
cell attachment as requirements for TJ formation in epithelial
cells and TE cell differentiation (Wiley, 1984; Contreras et al.,
1999; Rajasekaran et al., 2001a,b). Treatment of mammalian
preimplantation embryos with the Na+-pump inhibitor ouabain
blocked blastocyst formation (Wiley, 1984). Prolonged oua-
bain blockade of Na+/K+-ATPase activity detached cultured
cell lines from each other and their substrate (Contreras et al.,
1999). Inhibition of Na+/K+-ATPase either with ouabain or K+
depleted medium prevented TJ and desmosome formation in
MDCK cells (Rajasekaran et al., 2001a,b). In cultures of
human retinal pigment epithelial cells, inhibition of the Na+-
pump by ouabain treatment or exposure to K+ depleted
medium decreased trans-epithelial cell resistance and in-
creased permeability of TJs to mannitol and insulin (Rajase-
karan et al., 2003a,b). These studies have provided a
foundation for our hypothesis, that Na+/K+-ATPase is an
important mediator of TE TJ formation and function during
blastocyst development.
The results demonstrated that 107 M ouabain did not affect
blastocyst development, while at higher concentrations (103
M), long-term ouabain treatment blocked development at the 8-
cell stage. Ouabain specifically inhibits Na+/K+-ATPase
activity by binding to a domain located on the a-subunit
(Kawamura et al., 1999). K+ competes with ouabain for
binding sites on the Na+/K+-ATPase (Price and Lingrel,
1988; Johnson et al., 1995). Ouabain can stimulate enzyme
activity at lower concentrations and inhibit enzyme activity at
higher concentrations (Wiley, 1984; Schoner, 2002). The cation
gradients maintained by the Na+/K+-ATPase are needed in
many cells to maintain protein synthesis. Ouabain (103 M)
treatment slows or blocks formation of the mouse blastocyst
cavity (DiZio and Tasca, 1977; Wiley, 1984; Manejwala et al.,
1989; Betts et al., 1998). In addition, rodent cells are resistant
Fig. 5. FITC-Dextran Fluorescence. Representative images of FITC-dextran
fluorescence within the blastocyst cavity of ouabain treated embryos at 3 h (A–
D) and 6 h (E–H). Figures represent non treated controls cultured in KSOMaa
medium (A, E), KSOMaa plus 103 M ouabain (B, F), K+-free KSOMaa (C,
G), and KSOMaa plus EGTA (D, H). Treated embryos displayed a significant
increase in the number of embryos permeable to 40 kDa FITC-dextran
compared to controls [KSOMaa] (A, E). Scale bars = 100 Am.
Table 3
FITC-dextran permeability in embryos treated with low ouabain concentrations
6 h Ouabain treatment 4 kDa FITC-dextran
Treatment group No. of embryos
examined
No. of permeable
embryos (5)
KSOMaa 109 18 (16.5%)
103 M Ouabain 110 49 (44.5%)*
K+-free 95 31 (32.6%)*
EGTA 104 57 (54.8%)*
104 M Ouabain 111 24 (21.6%)
105 M Ouabain 97 24 (24.7%)
* Significantly different from control by Dunn’s.
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to ouabain treatment and are typically unresponsive to
concentrations of ouabain less than 103 M, which explains
why this ouabain concentration has been characterized for use
in studies directed at defining the role of the Na+/K+-ATPase in
mouse blastocyst formation (DiZio and Tasca, 1977; Betts et
al., 1998; Mercer, 1993; Lingrel and Kuntzweiler, 1994).
Despite having an influence on overall cell number, treatment
with 105 M ouabain also did not affect blastocyst develop-
ment. Since 107 M ouabain did not have any measurable
effect it was removed from succeeding experiments that instead
employed 105 M, 104 M and 103 M ouabain concentra-
tions. In contrast to the findings of the long-term treatment
experiment, short term treatment with 103 M ouabain for up
to 6 h did not affect development to the blastocyst stage or
embryo cell number.
DiZio and Tasca (1977) employed cytochalasin-d treatment
for the purpose of disrupting TE TJ and to enable the
investigation of the effects of ouabain treatment on blastocyst
formation. Cytochalasin-d disrupts actin microfilaments,
which results in the breakdown of a cortical microfilamentous
cytoskeleton (Cooper, 1987). This causes a disruption of the
TJ seal which is anchored to the actin cytoskeleton through
associated cytoplasmic proteins (Fleming and Hay, 1991). In
the present study, removal of cytochalasin from the medium
and its replacement with drug-free medium resulted in a re-
expansion of all embryos and a return to a normal continuous
ZO-1 protein distribution associated with the apical contact
points between adjacent TE cells. In contrast, neither
blastocyst re-expansion nor return to a normal ZO-1 protein
distribution was observed when cytochalasin-d collapsed
embryos were transferred to medium containing 103 M
ouabain. These results support our primary hypothesis by
suggesting that Na+/K+-ATPase is required to promote the
reformation of TJ following cytochalasin-d collapse. Further-
more, the results indicated that ZO-1 following 3 h of ouabain
treatment was detected as a discontinuous fluorescence line
along the TE cell margins. By 6 h, ZO-1 fluorescence was
decreased in the 103 M ouabain group, and there was little
presence of a continuous linear pattern as seen in the control
groups. ZO-1 protein in preimplantation embryos is first
observed at the compacting 8-cell stage, coincident with or
just after development of basolateral cell adhesion and the
appearance of apical microvillous polarity (Fleming et al.,
1989). Initially, ZO-1 is present as a series of spots along the
boundary between free and apposed cell surfaces in intact
embryos, but becomes more linear with blastocyst TE cells
becoming surrounded by a continuous apical ZO-1 fluorescent
belt (Fleming et al., 1989). During compaction and the early
phases of apical junction formation, ZO-1 transiently co-
localizes with the catenin proteins in a single, permeable,
apicolateral ‘‘intermediate’’ junctional complex (Fleming et al.,
2000a,b). Subsequently, after occludin assembly in the late
morula, the apical junctional complex segregates into two
distinct structural domains (apical TJs; subjacent AJs) coinci-
dent with the apical separation of ZO-1 together with other
TJs associated proteins from the E-cadherin complex thus
establishing a permeability seal (Sheth et al., 2000b). Once
this permeability seal forms the blastocyst cavity begins to
expand (Sheth et al., 2000a).
One of the most dramatic outcomes we observed were that
both treatment with 103 M ouabain and culture in K+-free
KSOMaa medium resulted in a marked reduction in occludin
immunofluorescence. Occludin is a integral TJ protein that has
four transmembrane regions and a long terminal cytoplasmic
domain (Furuse et al., 1994). Experiments have determined that
ZO-1 is directly associated with occludin and this association is
required to maintain occludin’s position within the TJ (Furuse et
al., 1994; Umeda et al., 2004). Based upon our outcomes, we
would propose that blockade of Na/K-ATPase results in
disruption of ZO-1 distribution which is then followed by
affects to occludin distribution. However, despite their compel-
ling nature, our ZO-1 and occludin immunofluorescence studies
do not reveal the functional consequences of ouabain treatment
on the TE TJ. To investigate the functional links, we proceeded
with experiments to investigate the influence of ouabain
treatment on TJ permeability.
The results from the FITC-dextran permeability experi-
ments demonstrated that blastocysts treated with 103 M
ouabain for up to 6 h and cultured in K+-free KSOMaa
significantly increased their permeability to 4 kDa and 40
kDa FITC-dextran. In contrast, these embryos did not
display a high degree of permeability to 70 kDa FITC-
dextran. Thus we have demonstrated that ouabain treatment
or culture in K+-free KSOMaa results in a clear shift in the
proportion of embryos that maintain an impermeable TJ
seal. Interestingly, the seal does not become completely
permeable as it is still capable of excluding movement of 70
kDa dextran. Thus, the effect of ouabain treatment or culture
in K+-free KSOMaa on TJ function is selective, suggesting
that TJ function in the early embryo is subject to multiple
modes of regulation.
TJs consist of a complex of several transmembrane proteins
including the claudin family in addition to occludin; the
increased permeability may result from a shift of major TJ
proteins during the transition from the morula to the late
expanding blastocyst (Fleming et al., 1993; Tsukita and Furuse,
2000; Furuse et al., 2002; Gonzalez-Mariscal et al., 2003).
Occludin is involved in the establishment and maintenance of
the permeability seal in early stage blastocysts (Sheth et al.,
2000b). Post-translational modification (i.e., phosphorylation)
of integral components of the TJ, in addition to protein
interactions within the TJ complex, are important for main-
taining the blastocyst TJ permeability barrier (Sheth et al.,
2000a,b). We would conclude that the disruption of ZO-1 TJ
protein distribution observed in the present study signals
structural re-arrangements of TJ proteins such as we observed
for occludin following ouabain treatment that could result in
the increased permeability to FITC-Dextran. Support for this
conclusion comes from studies that have examined affects to
TJ permeability following knockdown of occludin (Yu et al.,
2005; Matlin, 2005). This possibility is also consistent with the
proposed mechanisms underlying an increase in paracellular
ionic permeability caused by Na+/K+-ATPase inhibition in
cultured cell lines (Contreras et al., 1999; Rajasekaran et al.,
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2001a,b, 2003a,b). The results therefore support that Na+/K+-
ATPase is a regulator of TJ paracellular permeability in mouse
blastocysts.
Previous studies demonstrated that loss of TJ structure
and increased paracellular permeability is linked to the
disruption of the circumferential actin ring that is localized
at the apical pole of polarized epithelial cells (Cooper, 1987;
Fleming et al., 1989; Sheth et al., 2000a,b). A reduction in
stress fibers projecting from the pre-junctional actin ring, is
associated with the loss of TJ membrane contact points and
increased TJ permeability in human retinal pigment epithelial
cells (Rajasekaran et al., 2003a,b). In MDCK cells, loss of
TJ permeability upon Na+/K+-ATPase inhibition also is
associated with reduced stress fiber content and reduced
RhoA GTPase activity (Rajasekaran et al., 2001a,b). Several
studies have shown that RhoA GTPase function is also
involved in the modulation of TJ structure and function
(Rajasekaran et al., 2001a,b) and now even with regulation
of occludin function (Yu et al., 2005; Matlin, 2005).
Overexpression of wild-type RhoA GTPase bypassed the
inhibitory effect of Na+/K+-ATPase inhibition on TJ forma-
tion, indicating that RhoA GTPase is an essential component
downstream of Na+/K+-ATPase and also linking Na+/K+-
ATPase to the formation of functional TJs (Rajasekaran et
al., 2001a,b). Other mechanisms that cannot be ruled out
include changes in signaling pathways by the intracellular
Na+ increase or K+ decrease caused by inhibition of Na+/K+-
ATPase that might alter TJ permeability (Rajasekaran and
Rajasekaran, 2003). Na+/K+-ATPase-mediated signaling
mechanisms involved in the regulation of RhoA GTPase
and actin assembly will be an important area of future
research that will provide more insight into how ion home-
ostasis might regulate the role of stress fibers in the
assembly and function of TJs.
In conclusion, inhibition of Na+/K+-ATPase with ouabain or
K+-free medium may randomize the site of ZO-1 membrane
assembly and delay its occurrence. Therefore, while E-cadherin
clearly is essential for initial events that trigger the transloca-
tion of ZO-1 to the plasma membrane (Rajasekaran et al.,
1996). Na+/K+-ATPase may be crucial for events that regulate
formation of an undisrupted ZO-1 ring, ZO-1-occludin inter-
actions and thus a functional TJ, and consequently completion
of TE differentiation. Functional studies to determine the
signaling mechanisms that control TJ formation will be
required to clarify the role of Na+/K+-ATPase in TJ mainte-
nance in the apical trophectodermal membrane domain of
mouse embryos.
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